News

Devyser and Dahui Biotech sign distribution deal for the Chinese market

Devyser, pioneer in diagnostic kits for complex DNA testing, and Dahui Biotech, major supplier of biotech and diagnostic products, announce today the signing of a new partnership for distribution of Devyser’s market leading test kits for rapid prenatal aneuploidy diagnostics in China. Ulf Klangby, CEO and founding partner of Devyser, says, “there is an increasing …

Devyser and Dahui Biotech sign distribution deal for the Chinese market Read More »

Devyser utser Ernst Westman till ny styrelseordförande

Med lång internationell erfarenhet av både diagnostik- och life scienceindustri är det en starkt meriterad industrialist som valts till ny styrelseordförande i Devyser Holding AB. Ernst Westman är civilingenjör i kemiteknik med specialisering inom medicinsk molekylärbiologi. Han grundade Boule Diagnostics 1994 och var VD och koncernchef till 31 mars 2017. Boule Diagnostics är idag världsledande inom …

Devyser utser Ernst Westman till ny styrelseordförande Read More »

Devyser opens subsidiary in Germany

Devyser announces the opening of Devyser GMBH near Frankfurt, Germany, to strengthen its local presence. Serving the German, Austrian and Swiss markets where Devyser has experienced strong growth in recent years. Download the full pressrelease using this link

JSI develops customized software plug-in for Devyser’s new NGS products

Devyser and JSI medical systems announce a joint solution for in-house processing of next-generation sequencing (NGS) data. The software platform provided by JSI has a newly developed plug-in that is compatible with all Devyser NGS products, including Devyser BRCA and Devyser CFTR. The solution is now available for all customers using the JSI sequence pilot …

JSI develops customized software plug-in for Devyser’s new NGS products Read More »

Devyser and Sophia Genetics partner to simplify routine diagnostics

Devyser and Sophia Genetics partner to simplify routine diagnostics using next-generation DNA sequencing Devyser, pioneer in diagnostic kits for complex DNA testing and Sophia Genetics, global leader in data-driven medicine, announce today the signing of a new partnership to simplify the adoption of next-generation DNA sequencing (NGS) for routine diagnostic laboratories. Under the terms of the …

Devyser and Sophia Genetics partner to simplify routine diagnostics Read More »

New board members appointed

Devyser holding ab announced at its annual general meeting yesterday the appointment of two new board members, Ernst Westman and Lars Höckenström. Ernst Westman is CEO of the boule diagnostics group since 22 years. Lars Höckenström is currently a senior adviser at Stockholm corporate finance. Chairman of the board Mia Arnhult comments: “I am delighted …

New board members appointed Read More »

New Devyser AZF V2 and AZF Extension Kits now available

Both products are fully compliant with the revised EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions. The new kits kit include all EAA/EMQN recommended markers for AZF microdeletion screening and extension analysis. A full overview of the markers included in the Devyser AZF v2 and Devyser AZF Extension kits can be found among …

New Devyser AZF V2 and AZF Extension Kits now available Read More »